2022 annual financial data
Century Therapeutics 2022 Operating margin
Century Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -2,574.17%.
Operating income was -133,831,000 USD and net income was -130,932,000 USD.
Operating cash flow was 14,052,000 USD.
Get free Century Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,199,000 USD
- Operating income
- -133,831,000 USD
- Net income
- -130,932,000 USD
- Operating cash flow
- 14,052,000 USD